Why stop at $221 billion? Drug companies are entering another round of dealmaking, after plowing past the global record.Teva Pharmaceutical Industries Ltd.’s $40.5 billion agreement Monday to purchase Allergan Plc’s generic-medicines business puts the mechanism in place to trigger more takeovers.
Hey, check out all the research scientist jobs. Post your resume today!
